Impact of COVID-19-related care disruptions on cervical cancer screening in the United States.

ABSTRACT:

Objectives

To quantify the secondary impacts of the COVID-19 pandemic disruptions to cervical cancer screening in the United States, stratified by step in the screening process and primary test modality, on cervical cancer burden.

Methods

We conducted a comparative model-based analysis using three independent NCI Cancer Intervention and Surveillance Modeling Network cervical models to quantify the impact of eight alternative COVID-19-related screening disruption scenarios compared to a scenario of no disruptions. Scenarios varied by the duration of the disruption (6 or 24 months), steps in the screening process being disrupted (primary screening, surveillance, colposcopy, excisional treatment), and primary screening modality (cytology alone or cytology plus human papillomavi

SUBMITTER: Burger EA 

PROVIDER: S-EPMC8484743 | biostudies-literature | 2021 Jun

REPOSITORIES: biostudies-literature